There was no difference in the primary outcome at a median of 3.4 years, despite a high event rate in both arms.

RT @UKheartresearch: ‼️Ischaemia does not predict prognosis or response to PCI 📣patients enrolled in @REVIVED_BCIS2 had LVEF<35% extensive…

@lvjulien_md @ehj_ed @divaka_perera @DrMattRyan @achir76 @mattlkw @hollymorgs @sohaibnazir @mmamas1973 @DrAsifQasim @CMichaelGibson @DrMarthaGulati @JACCJournals @SaadEzad @mbmcentegart @OPCILive The @JACCJournals paper reports core lab adjudicated angiographic data and the current @ehj_ed @escardio paper reports the myocardial consequences of that CAD (the high angiographic BCIS-jeopardy score correlates with a large amount of LV myocardium that is ischaemic or scarred)

@lvjulien_md @ehj_ed @divaka_perera @DrMattRyan @achir76 @mattlkw @hollymorgs @sohaibnazir @mmamas1973 @DrAsifQasim @CMichaelGibson @DrMarthaGulati Was published earlier this year @JACCJournals @SaadEzad @mbmcentegart et al Paper was also discussed by @divaka_perera @OPCILive recently 🎬

RT @UKheartresearch: Still more evidence that ischaemia doesn’t identify stable CAD patients who benefit from revascularisation: #ISCHEMIA…

Deep dive into completeness of revascularisation in REVIVED, ISCHEMIA and other trials @OPCILive by @divaka_perera @JWMoses @djc795 @ziadalinyc and @PaulSap9. 🎬 📖 @JACCJournals @kingscardio @NIHRresearch @BCIS_uk

RT @hollymorgs: Fascinating talks using pooled data from REVIVED (R) + STICH (S) ➡️ R patients had higher baseline surgical risk ➡️ No diff…

How do we reconcile STICH and REVIVED? Would CABG offer survival benefit with contemporary medical therapy? ➡️ Answers at late breaking science session #ESCCongress2024 this morning! Results from the first pooled individual patient level analyses from these two RCTs

Ischemia analysis of REVIVED #ESCCongress 💜 approx 20% of LV scarred 30% ischemic on CMR 🏥 very high rates of death or aborted sudden death 📈 amount of ischemia not associated with risk of events 📈 no benefit of PCI whether ischemia extensive or mild/moderate

RT @DrPeterOKane: Fantastic today that 2 landmark RCTs our centre @UHD_NHS recruited patients for impacted ESC guidelines to direct future…

ESC guidelines for PCI in severe LV impairment changed from 2a LoE C (should be done in most patients, based on consensus) to 2b LoE B (may be done in selected patients, based on randomised data).#ESCCongress 🙏🏽@REVIVED_BCIS2 investigators for providing the supporting evidence

Join us this Friday 30th at the #ESCCongress for the final piece of the REVIVED puzzle! 🧩 ➡️ How ischaemic were the patients enrolled in REVIVED? ➡️ Did ischaemic burden identify patients most likely to benefit from PCI? 12:15pm @ Science Box 4!

RT @markcpetrie20: @JACCJournals @SaadEzad @mbmcentegart @UKheartresearch We have to challenge dogma and firmly held views with data. REVI…

RT @JACCJournals: #EuroPCR #JACC LBCT SimPub: Insights from #REVIVED-BCIS2 trial - Completeness of #revascularization, whether anatomical o…

Interesting panel discussion #EuroPCR @Dr_AshokSeth @mbmcentegart ➡️ Would PCI have been beneficial in those with high ischaemic burden? Well.. not long to wait for these results! To be presented at #ESC2024 30th August 12pm @hollymorgs @divaka_perera @achir76

RT @hollymorgs: Come and join us this morning at 'Randomised trials: substudies and extended follow up' for the @REVIVED_BCIS2 completeness…

RT @divaka_perera: Thanks to hours of work by independent angio and viability core labs, a carefully designed analysis plan and our dedicat…

RT @UKheartresearch: 35% voted for OMT; of those opting for PCI 42% would do complete ANATOMICAL revasc and 35% VIABILITY-guided revasc (a…

RT @UKheartresearch: How would you manage this patient? A. Complete anatomical revasc (PCI LAD, LCx and RCA) B. Revasc of all viable segme…